Last reviewed · How we verify
Bromfenac Ophthalmic 0.09% Ophthalmic Solution
Bromfenac Ophthalmic 0.09% Ophthalmic Solution is a Small molecule drug developed by Klinički Bolnički Centar Zagreb. It is currently FDA-approved. Also known as: Bromfenac.
At a glance
| Generic name | Bromfenac Ophthalmic 0.09% Ophthalmic Solution |
|---|---|
| Also known as | Bromfenac |
| Sponsor | Klinički Bolnički Centar Zagreb |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparing Efficacy of Bromfenac 0.09%, Nepafenac 0.3% and Diclofenac 0.1% in Patients After Cataract Surgery (NA)
- Bromfenac Versus Dexamethasone After Cataract Surgery (PHASE4)
- Bromfenac to Reduce Inflammation in Patients With Pseudoexfoliation Syndrome After Cataract Surgery (PHASE4)
- Effects of Bromfenac on Macular Thickness After Phacoemulsification Surgery (PHASE4)
- Effectiveness of Periocular Drug Injection in CATaract Surgery (PHASE3)
- Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection. (PHASE4)
- Control of Pain in Intravitreal Injections Using Topical NSAIDs (PHASE4)
- Comparison of Treatments in Diabetic Macular Edema (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bromfenac Ophthalmic 0.09% Ophthalmic Solution CI brief — competitive landscape report
- Bromfenac Ophthalmic 0.09% Ophthalmic Solution updates RSS · CI watch RSS
- Klinički Bolnički Centar Zagreb portfolio CI
Frequently asked questions about Bromfenac Ophthalmic 0.09% Ophthalmic Solution
What is Bromfenac Ophthalmic 0.09% Ophthalmic Solution?
Bromfenac Ophthalmic 0.09% Ophthalmic Solution is a Small molecule drug developed by Klinički Bolnički Centar Zagreb.
Who makes Bromfenac Ophthalmic 0.09% Ophthalmic Solution?
Bromfenac Ophthalmic 0.09% Ophthalmic Solution is developed and marketed by Klinički Bolnički Centar Zagreb (see full Klinički Bolnički Centar Zagreb pipeline at /company/klini-ki-bolni-ki-centar-zagreb).
Is Bromfenac Ophthalmic 0.09% Ophthalmic Solution also known as anything else?
Bromfenac Ophthalmic 0.09% Ophthalmic Solution is also known as Bromfenac.
What development phase is Bromfenac Ophthalmic 0.09% Ophthalmic Solution in?
Bromfenac Ophthalmic 0.09% Ophthalmic Solution is FDA-approved (marketed).
Related
- Manufacturer: Klinički Bolnički Centar Zagreb — full pipeline
- Also known as: Bromfenac
- Compare: Bromfenac Ophthalmic 0.09% Ophthalmic Solution vs similar drugs
- Pricing: Bromfenac Ophthalmic 0.09% Ophthalmic Solution cost, discount & access